Neurovascular unit dysfunction: a vascular component of Alzheimer disease?
Benarroch
Eduardo E
EE
D000544:Alzheimer Disease / Q000473:pathology* / Q000503:physiopathology / Q000517:prevention & control; D016229:Amyloid beta-Peptides / Q000378:metabolism; D016564:Amyloid beta-Protein Precursor / Q000378:metabolism; D000818:Animals; D001253:Astrocytes / Q000378:metabolism; D001692:Biological Transport; D001812:Blood-Brain Barrier / Q000502:physiology*; D020013:Calcium Signaling; D002196:Capillaries / Q000503:physiopathology; D002412:Cations / Q000378:metabolism; D002560:Cerebrovascular Circulation / Q000502:physiology*; D004730:Endothelium, Vascular / Q000378:metabolism; D004734:Energy Metabolism; D006801:Humans; D006940:Hyperemia / Q000503:physiopathology; D051379:Mice; D008822:Mice, Transgenic; D008954:Models, Biological; D009474:Neurons / Q000378:metabolism; D018377:Neurotransmitter Agents / Q000502:physiology; D020286:Pericytes / Q000502:physiology; D010841:Pia Mater / Q000098:blood supply; D009435:Synaptic Transmission; D014664:Vasodilation
D016229:Amyloid beta-Peptides; D016564:Amyloid beta-Protein Precursor; D002412:Cations; D018377:Neurotransmitter Agents